Stock BSEM BIOSTEM TECHN.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases BioStem Techn. OTC Markets

Equities

BSEM

US0906842002

Market Closed - OTC Markets
Other stock markets
 15:59:55 2024-05-17 EDT 		5-day change 1st Jan Change
8.14 USD -9.66% Intraday chart for BioStem Techn. +1.12% +38.91%
05-14 Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M MT
2023 NovaBay to Commercialize BioStem's Amniotic Tissue Allograft MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
AQ
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
AQ
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
AQ
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
AQ
BioStem Technologies to Present at the 2024 Planet MicroCap Showcase
AQ
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
AQ
BioStem Technologies to Present at the 14th Annual LD Micro Invitational Conference
AQ
BioStem Technologies Reports Fourth Quarter Revenue of $11.5 Million, 14-Fold YoY Increase
AQ
BioStem Technologies to Report Fourth Quarter 2023 Financial Results on Monday, April 01, 2024
AQ
PRISM MarketView Spotlights BioStem Technologies in the Expanding Wound Care Market
AQ
Amniowrap2™ Product Launch Leads Year of Highlights for BioStem Technologies
AQ
BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role
AQ
BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors
AQ
Center for Medicare Services Established National Pricing of AmnioWrap2™ in All MAC Regions
AQ
BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors
AQ
BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results
AQ
BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services
AQ
BioStem Technologies Closes Oversubscribed $2M Private Placement
AQ
BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
AQ
NovaBay Pharmaceuticals Announces Commercial Launch of Avenova Allograft
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. BSEM Stock
  5. News BioStem Techn.
  6. Press Releases
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW